MicroBiomeGSM: The Identification of Taxonomic Biomarkers From Metagenomic Data Using Grouping, Scoring and Modeling (G-S-M) Approach
Loading...
Date
2023
Journal Title
Journal ISSN
Volume Title
Publisher
Frontiers Media S.A.
Open Access Color
GOLD
Green Open Access
Yes
OpenAIRE Downloads
80
OpenAIRE Views
115
Publicly Funded
No
Abstract
Numerous biological environments have been characterized with the advent of metagenomic sequencing using next generation sequencing which lays out the relative abundance values of microbial taxa. Modeling the human microbiome using machine learning models has the potential to identify microbial biomarkers and aid in the diagnosis of a variety of diseases such as inflammatory bowel disease, diabetes, colorectal cancer, and many others. The goal of this study is to develop an effective classification model for the analysis of metagenomic datasets associated with different diseases. In this way, we aim to identify taxonomic biomarkers associated with these diseases and facilitate disease diagnosis. The microBiomeGSM tool presented in this work incorporates the pre-existing taxonomy information into a machine learning approach and challenges to solve the classification problem in metagenomics disease-associated datasets. Based on the G-S-M (Grouping-Scoring-Modeling) approach, species level information is used as features and classified by relating their taxonomic features at different levels, including genus, family, and order. Using four different disease associated metagenomics datasets, the performance of microBiomeGSM is comparatively evaluated with other feature selection methods such as Fast Correlation Based Filter (FCBF), Select K Best (SKB), Extreme Gradient Boosting (XGB), Conditional Mutual Information Maximization (CMIM), Maximum Likelihood and Minimum Redundancy (MRMR) and Information Gain (IG), also with other classifiers such as AdaBoost, Decision Tree, LogitBoost and Random Forest. microBiomeGSM achieved the highest results with an Area under the curve (AUC) value of 0.98% at the order taxonomic level for IBDMD dataset. Another significant output of microBiomeGSM is the list of taxonomic groups that are identified as important for the disease under study and the names of the species within these groups. The association between the detected species and the disease under investigation is confirmed by previous studies in the literature. The microBiomeGSM tool and other supplementary files are publicly available at: https://github.com/malikyousef/microBiomeGSM.
Description
Temiz, Mustafa/0000-0002-2839-1424;
ORCID
Keywords
Gut Microbiome, Metagenomics, Type 2 Diabetes, Inflammatory Bowel Disease, Colorectal Cancer, Machine Learning, Classification, Feature Selection, metagenomics, feature selection, machine learning, classification, inflammatory bowel disease, gut microbiome, colorectal cancer, type 2 diabetes, Microbiology, QR1-502
Fields of Science
Citation
WoS Q
Q1
Scopus Q
Q1

OpenCitations Citation Count
9
Source
Frontiers in Microbiology
Volume
14
Issue
Start Page
End Page
PlumX Metrics
Citations
Scopus : 13
PubMed : 1
Captures
Mendeley Readers : 23
Google Scholar™


